Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
Top Cited Papers
- 1 January 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9252) , 280-281
- https://doi.org/10.1016/s0140-6736(00)03618-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis BNew England Journal of Medicine, 1995
- Toxicologic effects of ribavirin in catsJournal of Veterinary Pharmacology and Therapeutics, 1993
- Embryotoxic, teratogenic, and metabolic effects of ribavirin in miceToxicology and Applied Pharmacology, 1980